Skip to content

Dried Purple Laver (Nori) as a Food Source of Vitamin B12 in Vegetarians

The Bioavailability of Vitamin B12 From Nori in Vegetarians: a Dose Response Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05614960
Enrollment
30
Registered
2022-11-14
Start date
2022-11-07
Completion date
2023-03-31
Last updated
2023-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin B 12 Deficiency

Keywords

Vitamin B12, Vegetarian diet, Purple laver (Porphyra sp.), Nori

Brief summary

This is an intervention study aiming to understand the bioavailability of vitamin B12 from nori for vegetarians.

Detailed description

Thirty vegetarian participants will be randomly assigned to one of three intervention arms: (1) 5g of nori (4 sheets, containing 2.4μg vitamin B12), (2) 8g nori (7 sheets, containing 4μg vitamin B12), (3) control group (no nori). At baseline and end of 4 weeks, participants will be measured on serum vitamin B12, methylmalonic acid, holotranscobalamin, homocysteine and folate.

Interventions

OTHERDried purple laver (Nori)

Dried purple laver (Nori) that has been test to have bioactivity vitamin B12 will be given for intervention groups.

Sponsors

Fu Jen Catholic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Vegetarians (including vegan, ovo-vegetarian, lacto-vegetarian, lacto-ovo vegetarian) * Duration of the vegetarian diet: at least 1 year * Aged 20-60 years old * Have not taken vitamin B12 or folate supplement within 1 year * Willing to adhere to study intervention and be tested for vitamin B12 related biomarkers. * Familiar with LINE application on smartphone

Exclusion criteria

* Any disease or surgery that affects the vitamin B12 status (Pernicious anemia, Gastrointestinal disease and surgery, Pancreatic diseases, Chronic kidney disease) * Hyperthyroidism * Previous adverse reaction to nori * Have taken antacid or metformin in the past 1 week * Alcoholic and not willing to abstinence from alcoholic beverages

Design outcomes

Primary

MeasureTime frameDescription
Change in holotranscobalamin in 4 weeks4 weeks (Week 4 - Baseline)Assessing the change in serum holotranscobalamin after consuming varying doses of nori
Change in methylmalonic acid in 4 weeks4 weeks (Week 4 - Baseline)Assessing the change in serum methylmalonic acid after consuming varying doses of nori

Secondary

MeasureTime frameDescription
Change in serum vitamin B12 concentration in 4 weeks4 weeks (Week 4 - Baseline)Assessing the change in serum vitamin B12 after consuming varying doses of nori
Change in homocysteine in 4 weeks4 weeks (Week 4 - Baseline)Assessing the change in serum homocysteine after consuming varying doses of nori

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026